Zimmermann R, Hucha A, Savoldelli G, Binkert F, Achermann J, Grudzinskas J G
Department of Obstetrics, University Hospital, Zurich, Switzerland.
Br J Obstet Gynaecol. 1996 Oct;103(10):1009-14. doi: 10.1111/j.1471-0528.1996.tb09552.x.
To assess the relation between serum parameters and nuchal translucency in pregnancies affected by fetal aneuploidy in the first trimester.
Retrospective study of different serum parameters collected prior to chorionic villus sampling and measurement of nuchal translucency in relation to fetal aneuploidy.
Switzerland (German and Italian sector) and Bregenz, Austria.
One thousand one hundred and fifty-one women aged 25 to 44 years at 10 to 13 weeks of gestation undergoing chorionic villus sampling, mostly for advanced maternal age. Fetal aneuploidy was found in 23 pregnancies including four cases of trisomy 21, five of trisomy 18 and one case of trisomy 13.
Fetal karyotype, serum levels of free beta-hCG, pregnancy-associated plasma protein A (PAPP-A) and alpha-fetoprotein and the measurement of nuchal translucency.
Serum PAPP-A was decreased in all common chromosomal abnormalities. Free beta-hCG levels were increased in trisomy 21 but decreased in trisomy 18, whereas alpha-fetoprotein was low in trisomy 21, 18 and other chromosomal abnormalities. Nine of twenty-three abnormal embryos had evidence of an increased nuchal translucency. Nuchal translucency, however, did not seem to be associated with any alteration in the levels of the biochemical parameters in either chromosomally normal or abnormal embryos. A low serum PAPP-A or an increased nuchal translucency was seen in two-thirds of all pregnancies with chromosomal abnormalities.
A nuchal translucency > or = 3 mm and depressed serum PAPP-A levels have a good predictive value in the detection of fetal aneuploidy at 10 to 13 weeks of pregnancy. Serum free beta-hCG and alpha-fetoprotein levels may give additional information. An increased nuchal translucency was not associated with altered serum parameters. This would allow these different markers to be used in combination.
评估孕早期胎儿非整倍体妊娠中血清参数与颈部半透明厚度之间的关系。
对绒毛取样前收集的不同血清参数以及与胎儿非整倍体相关的颈部半透明厚度测量值进行回顾性研究。
瑞士(德语区和意大利语区)以及奥地利布雷根茨。
1151名年龄在25至44岁之间、妊娠10至13周且接受绒毛取样的女性,多数因产妇年龄偏大。23例妊娠中发现胎儿非整倍体,其中包括4例21三体、5例18三体和1例13三体。
胎儿核型、游离β-人绒毛膜促性腺激素(β-hCG)、妊娠相关血浆蛋白A(PAPP-A)和甲胎蛋白的血清水平以及颈部半透明厚度测量值。
所有常见染色体异常中血清PAPP-A均降低。21三体时游离β-hCG水平升高,18三体时降低,而21三体、18三体及其他染色体异常中甲胎蛋白水平均较低。23例异常胚胎中有9例颈部半透明厚度增加。然而,无论是染色体正常还是异常的胚胎,颈部半透明厚度似乎均与生化参数水平的任何改变无关。所有染色体异常妊娠中有三分之二出现血清PAPP-A低或颈部半透明厚度增加。
颈部半透明厚度≥3 mm及血清PAPP-A水平降低对于妊娠10至13周时胎儿非整倍体的检测具有良好的预测价值。血清游离β-hCG和甲胎蛋白水平可能提供额外信息。颈部半透明厚度增加与血清参数改变无关。这使得这些不同的标志物可以联合使用。